(Q46225290)

20 December 2017

title

Asymptomatic chronic gastrointestinal blood loss in patients taking aspirin or warfarin for cardiovascular disease (English)

1 reference

20 December 2017

1 reference

cardiovascular disease

1 reference

1 reference

Greenberg PD

1

1 reference

20 December 2017

Cello JP

series ordinal

2

1 reference

20 December 2017

Rockey DC

series ordinal

3

1 reference

20 December 2017

language of work or name

English

0 references

publication date

1 June 1996

1 reference

20 December 2017

American Journal of Medicine

published in

1 reference

20 December 2017

volume

100

1 reference

20 December 2017

issue

6

1 reference

20 December 2017

page(s)

598-604

1 reference

20 December 2017

Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900009-5

Aspirin (75 mg/day) after an episode of unstable coronary artery disease: long-term effects on the risk for myocardial infarction, occurrence of severe angina and the need for revascularization. Research Group on Instability in Coronary Artery Disea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900009-5

The effect of warfarin on mortality and reinfarction after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900009-5

Final report on the aspirin component of the ongoing Physicians' Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900009-5

Low-dose warfarin and low-dose aspirin in the primary prevention of ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900009-5

Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900009-5

Fecal blood levels in health and disease. A study using HemoQuant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900009-5

HemoQuant, a new quantitative assay for fecal hemoglobin. Comparison with Hemoccult

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900009-5

Gastrointestinal blood loss from a new buffered aspirin (Ostoprin): measurement by radiochromium and Hemoquant techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900009-5

Effects of early intervention with low-dose aspirin (100 mg) on infarct size, reinfarction and mortality in anterior wall acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900009-5

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900009-5

Comparison of the specificity and sensitivity of Hemoccult and HemoQuant in screening for colorectal neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900009-5

10.1016/S0002-9343(96)00009-5

7 January 2021

Identifiers

DOI

1 reference

20 December 2017

PubMed ID

8678078

1 reference

20 December 2017